Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/17/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Jeffrey Sklar?

Jeffrey L. Sklar

Director of Molecular Diagnostics Program, Director of Molecular Genetics Pathology Fellowship and Director of Molecular Tumor Profiling Laboratory

Yale University

HQ Phone:  (203) 785-7026

Direct Phone: (203) ***-****direct phone

Email: j***@***.edu

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Yale University

333 Cedar St

New Haven, Connecticut,06510

United States

Company Description

Yale University, a preeminent global university founded in New Haven, Connecticut in 1701, consists of three major academic components: Yale College, for undergraduate liberal arts; the Graduate School of Arts and Sciences, offering advanced degrees in 73 depa...more

Background Information

Employment History

Director

UroCor , Inc.


Professor of Pathology

Harvard University


Associate Professor

Stanford University


Affiliations

NABsys , Inc.

Member, Scientific Advisory Board


Transgenomic Inc

Board Member


DIANON Systems , Inc.

Board Member Organization


PhyNexus Inc

Scientific Advisor


bioMérieux Inc

Scientific Advisory Board


HTS Biosystems , Inc.

Scientific Advisory Board


Genome Therapeutics

Scientific Advisory Board


Education

BA

Haverford College


M.D.

Yale University School of Medicine


MA

Harvard University


Web References(66 Total References)


yalecancercenter.org

Jeffrey Sklar, MD, PhD
Assistant Director, Pathology and Tissue Acquisition Services Jeffrey.sklar@yale.edu (203) 785-6828


chromatography.transgenomic.com

Jeffrey Sklar, M.D., Ph.D. - Director
Dr. Sklar is Professor of Pathology at Yale University School of Medicine. Previously, he was on the faculty of Stanford University and Harvard Medical School. He also serves as director of the Program in Molecular Diagnostic at Yale. Dr. Sklar serves on the editorial boards of numerous journals in the areas of pathology and cancer, and on scientific advisory committees: the Dana-Farber Cancer Center, Boston, MA; the Fred Hutchinson Cancer Center, Seattle, Washington; the New England Regional Primate Center; Harvard University; and the National Institutes of Health. He has served on the scientific advisory boards of numerous companies in the biotechnology field. Dr. Sklar holds an M.D. and Ph.D. from Yale University, and an M.A. (honorary) from Harvard University.


www.phynexus.com [cached]

Jeffrey Sklar, PhD, MD- Scientific Advisor
Professor Sklar is currently Professor of Pathology at Yale Medical School. Prior to this, he was a Professor at Harvard Medical School, and additionally was Director of the Divisions of Molecular Oncology and Diagnostic Molecular Biology at Brigham and Women's Hospital in Boston, Massachusetts. Sklar has published over 140 papers on fundamental and applied aspects of molecular diagnostics and molecular oncology, and co-authored the authoritative text "The Lymphomas. Sklar is a highly distinguished expert in the area of biochemical and molecular mechanisms of disease (particular cancers), and has published on and patented technologies for molecular disease diagnosis. Sklar has also served on the Board of Directors and Scientific Advisory Board of various organizations, including the Board of Directors of Dianon Systems and Transgenomic, and the Scientific Advisory Board of BioMerieux, Genome Therapeutics and HTS Biosystems.


www.phynexus.com [cached]

Jeffrey Sklar, PhD, MD- Scientific Advisor Professor Sklar is currently Professor of Pathology at Yale Medical School.Prior to this, he was a Professor at Harvard Medical School, and additionally was Director of the Divisions of Molecular Oncology and Diagnostic Molecular Biology at Brigham and Women's Hospital in Boston, Massachusetts.Sklar has published over 140 papers on fundamental and applied aspects of molecular diagnostics and molecular oncology, and co-authored the authoritative text "The Lymphomas."Sklar is a highly distinguished expert in the area of biochemical and molecular mechanisms of disease (particular cancers), and has published on and patented technologies for molecular disease diagnosis.Sklar has also served on the Board of Directors and Scientific Advisory Board of various organizations, including the Board of Directors of Dianon Systems and Transgenomic, and the Scientific Advisory Board of BioMerieux, Genome Therapeutics and HTS Biosystems.


www.phynexus.peachhost.com [cached]

Jeffrey Sklar, PhD, MD - Scientific AdvisorProfessor Sklar is currently Professor of Pathology at Yale Medical School.Prior to this, he was a Professor at Harvard Medical School, and additionally was Director of the Divisions of Molecular Oncology and Diagnostic Molecular Biology at Brigham and Women's Hospital in Boston, Massachusetts.Sklar has published over 140 papers on fundamental and applied aspects of molecular diagnostics and molecular oncology, and co-authored the authoritative text "The Lymphomas."Sklar is a highly distinguished expert in the area of biochemical and molecular mechanisms of disease (particular cancers), and has published on and patented technologies for molecular disease diagnosis.Sklar has also served on the Board of Directors and Scientific Advisory Board of various organizations, including the Board of Directors of Dianon Systems and Transgenomic, and the Scientific Advisory Board of BioMerieux, Genome Therapeutics and HTS Biosystems.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory